Please refer to our Scrutinizer''s Report of 56th Annual General Meeting of the Company.
Please refer to our Intimation of closure of Trading window for the declaration of un-audited financial results for the quarter and half year ending 30.09.2026
Please refer to our Intimation of change/updation in Email ID of Company Secretary and RTA.
Investors Presentation for the quarter ended 30.06.2026
Investors Presentation for the quarter ended 30.06.2026
Please refer to the attachment.
Please refer to the attachment.
Please refer to the intimation of appointment of Company Secretary & Compliance Officer and Key Managerial Personnel of the Company.
Kindly refer to the attachment.
Please refer to the outcome of the Board Meeting held on 13th August 2026.
Themis Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve the Standalone and Consolidated Un-Audited Financial Results for the quarter ended on 30th June, 2026 and Limited Review Reports of the Statutory Auditors thereon
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 30, 2026 for Vividhmargi Investments Pvt Ltd
The Exchange has received the revised Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on July 21, 2026 for Vividhmargi Trust
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 21, 2026 for Vividhmargi Trust
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 20, 2026 for Vividhmargi Investments Pvt Ltd
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 16, 2026 for Vividhmargi Investments Pvt Ltd
Please refer to the RTA Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018.
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on July 03, 2026 for Vividhmargi Trust
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 03, 2026 for Vividhmargi Trust
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CTL Trusteeship Ltd